BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 2187176)

  • 21. Is it safer to intubate premature infants in the delivery room?
    Aly H; Massaro AN; Patel K; El-Mohandes AA
    Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial.
    Escobedo MB; Gunkel JH; Kennedy KA; Shattuck KE; Sánchez PJ; Seidner S; Hensley G; Cochran CK; Moya F; Morris B; Denson S; Stribley R; Naqvi M; Lasky RE;
    J Pediatr; 2004 Jun; 144(6):804-8. PubMed ID: 15192630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
    Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
    Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
    Durand M; Sardesai S; McEvoy C
    Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.
    Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ
    N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
    Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
    Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of neonatal respiratory distress syndrome with Alveofact--results of a prospective observational study].
    Wauer RR; Schmalisch G; Rogalski M
    Klin Padiatr; 1996; 208(6):355-65. PubMed ID: 9064378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ; Davis PG; Doyle LW; Brion LP; Hascoet JM; Carlin JB;
    N Engl J Med; 2008 Feb; 358(7):700-8. PubMed ID: 18272893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome.
    Horbar JD; Soll RF; Schachinger H; Kewitz G; Versmold HT; Lindner W; Duc G; Mieth D; Linderkamp O; Zilow EP
    Eur J Pediatr; 1990 Mar; 149(6):416-23. PubMed ID: 2185026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants.
    Courtney SE; Durand DJ; Asselin JM; Hudak ML; Aschner JL; Shoemaker CT;
    N Engl J Med; 2002 Aug; 347(9):643-52. PubMed ID: 12200551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage.
    Pandit PB; Dunn MS; Colucci EA
    Pediatrics; 1995 Jan; 95(1):32-6. PubMed ID: 7770305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
    Smyth J; Allen A; MacMurray B; Peliowski A; Sankaran K; Volberg F; Shukla A; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.
    Speer CP; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; Harms K; Herting E; McClure G; Reid M
    Pediatrics; 1992 Jan; 89(1):13-20. PubMed ID: 1727997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surfactant replacement in neonates with early chronic lung disease.
    Pandit PB; Dunn MS; Kelly EN; Perlman M
    Pediatrics; 1995 Jun; 95(6):851-4. PubMed ID: 7761208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.
    Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D
    Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.
    Verder H; Robertson B; Greisen G; Ebbesen F; Albertsen P; Lundstrøm K; Jacobsen T
    N Engl J Med; 1994 Oct; 331(16):1051-5. PubMed ID: 8090164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inositol supplementation in premature infants with respiratory distress syndrome.
    Hallman M; Bry K; Hoppu K; Lappi M; Pohjavuori M
    N Engl J Med; 1992 May; 326(19):1233-9. PubMed ID: 1560798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled nitric oxide for premature infants with severe respiratory failure.
    Van Meurs KP; Wright LL; Ehrenkranz RA; Lemons JA; Ball MB; Poole WK; Perritt R; Higgins RD; Oh W; Hudak ML; Laptook AR; Shankaran S; Finer NN; Carlo WA; Kennedy KA; Fridriksson JH; Steinhorn RH; Sokol GM; Konduri GG; Aschner JL; Stoll BJ; D'Angio CT; Stevenson DK;
    N Engl J Med; 2005 Jul; 353(1):13-22. PubMed ID: 16000352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.